SCHEMBL12822160

SCHEMBL12822160

N#Cc1ccc(Oc2ccc(-n3cnc4ccc(C(=O)O)cc43)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 3/20 0.62
▸ PARP15 Q460N3 1/20 0.45
▸ PARP10 Q53GL7 1/20 0.45
▸ PARP2 Q9UGN5 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ PTPN11 Q06124 1/20 0.44
▸ HPGD P15428 3/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ NCOA1 Q15788 1/20 0.43
▸ NCOA3 Q9Y6Q9 1/20 0.43
▸ TDP2 O95551 1/20 0.42
▸ CHEK2 O96017 2/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12822152 0.91 FGFR1 (0.60) FGFR1THRBHPGDALDH1A1MAPK1
SCHEMBL12821995 0.91 FGFR1 (0.59) FGFR1HPGDALDH1A1MAPK1HTT
SCHEMBL12821909 0.90 FGFR1 (0.66) FGFR1THRBPTPN11HPGD
SCHEMBL12822123 0.87 FGFR1 (0.78) FGFR1THRBHPGDALDH1A1MAPK1
SCHEMBL12822187 0.84 FGFR1 (0.62) FGFR1HPGDALDH1A1MAPK1HTT
SCHEMBL15288227 0.84 FGFR1 (0.57) FGFR1THRBPTPN11
SCHEMBL25297465 0.83 FGFR1 (0.71) FGFR1THRBHPGDALDH1A1GSK3B
SCHEMBL30440825 0.83 FGFR1 (0.71) FGFR1THRBHPGDALDH1A1GSK3B
SCHEMBL12822175 0.81 FGFR1 (0.61) FGFR1PARP15PARP10PARP2CHEK2
SCHEMBL12822333 0.80 FGFR1 (0.62) FGFR1THRBHPGDGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012131501-A1 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AS COT KINASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2012-10-04 — — WO claimed
Send feedback